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Cell-Cell Fusion Mediated by the Fusion Protein of Ebola Virus
Ruben M. Markosyan1, Shan Lu Liu2, Fredric S. Cohen1.
1Rush University Medical Center, Chicago, IL, USA, 2University of
Missouri,, Columbia, MO, USA.
Despite the large number of infections caused by Ebolavirus (EboV), a model
system for fusing cells expressing the EboV fusion glyprotein (GP) to target
cells has not been developed. We have now done so. Cells expressing GP fused
to target cells at neutral pH without any explicit enzymatic treatment; acidifi-
cation of external solutions augmented the level of fusion. Independent of
pH, inhibiting cathespins by addition of either leupeptin or CA-074, to prevent
cleavage of GP into an active fusion protein, blocked virtually all fusion. Inten-
tionally cleaving GP into an active fusion protein, by treating effector cells with
thermolysin, greatly increased the amount of fusion at both neutral and acidic
pH, with fusion greater under acidic conditions. The cathespin inhibitors
reduced fusion of the thermolysin treated cells, albeit not completely. Thermo-
lysin treated GP became susceptible to proteinase K (pK): pK treatment of
cleaved GP severely reduced fusion. Several point GP mutants that severely
reduce infection almost completely eliminated fusion, establishing the reli-
ability of the model cell-cell fusion system. The time course of aqueous dye
spread between cells mediated by wild-type GP was exceptionally slow,
much slower than the rate of dye permeation through fusion pores mediated
by all other fusion proteins we have studied. The slow rate of dye transfer in-
dicates that the EboV GP-fusion pore remains small, thereby limiting diffusion
of aqueous molecules between cells. We conclude that sensitive assays relying
on transfer of large molecules, such as genes, have not detected cell-cell fusion
because the fusion pores remain too small to permit permeation. Our finding
that fusion can occur at neutral pH suggests that although augmented by low
pH, pH might be a facilitating, augmenting factor, rather than the biological
trigger for EboV-GP-mediated fusion.
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Investigation of Calcein for Reporting Content Mixing During Viral Mem-
brane Fusion Experiments
Laura Wessels1, Keith Weninger2.
1University of Nebraska-Kearney, Kearney, NE, USA, 2North Carolina State
University, Raleigh, NC, USA.
Simultaneous diagnosis of lipid mixing and content mixing during fusion of en-
veloped virus particle with a target liposome is critical for thorough understand-
ing of the completeness of the membrane fusion reaction. Here we have
investigated calcein for fluorescence detection of content mixing in virus fusion
experiments. Calcein was encapsulated into target liposomes and lipophilic
fluorescent dyes were incorporated into virus samples, both at self-quenching
concentrations, to allow hemifusion and full fusion to be distinguished by the
relative timing of the dequenching signals. We report that osmotic balancing
of the interior and exterior of the calcein-loaded vesicles is essential for these
experiments to reproduce native virus fusion behaviors.
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Mechanism of Action of Flufirvitide, a Peptide Inhibitor of Influenza Virus
Infection
Hussain Badani1, Robert F. Garry1, Thomas G. Voss2, Russell B. Wilson3,
William C. Wimley1.
1Tulane University, NewOrleans, LA, USA, 2SRI International, Harrisonburg,
VA, USA, 3Autoimmune Technologies, New Orleans, LA, USA.
Influenza infection is a membrane fusion-dependent process, occurring in the
endosome of the host cell after viral binding and endocytosis. The virus-host
membrane fusion process is mediated by hemagglutinin (HA), a viral surface
glycoprotein. Studies show that when the virus is subjected to low pH in the
endosome, the HA protein partially unfolds and changes conformation,
exposing the fusion initiation region (FIR). A 16 amino acid peptide sequence
(Flufirvitide) derived from the fusion initiation region of the HA protein has
shown effective inhibition of influenza virus infection. Plaque inhibition assays
and animal studies show high efficacy of the peptide against the virus. Howev-
er, the mechanism of action of this peptide is still unclear. Circular Dichroism
studies show that the peptide has a random coil conformation at pH 7 which
otherwise exists in the helical conformation in the native protein. Biophysical
analysis of the peptide indicates weak interaction with membrane bilayers at
pH 7 and stronger binding at endosomal pH 5.0. Confocal microscopy indicates
that the peptide can translocate inside cells without introducing cytotoxicity. It
is hypothesized that there is an interaction between the peptide and the virus
that inhibits fusion of the virus to the host cell. To test this hypothesis we
are studying the interaction between the peptide, HA and lipid membranes us-
ing immunodetection, immunoprecipitation, fluorescence and chromatographic
techniques. Additionally, binding of the peptide with to intact virus is beingstudied by cryo-electron microscopy and several different cell based assays
at different temperatures and pHs.
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Influenza Fusion Peptide and Transmembrane Domain Interaction In-
duces Distinct Domains in Lipid Bilayers
Alex Liqi Lai, Jack H. Freed.
Chemistry and Chemical Biology, Cornell University, Ithaca, NY, USA.
Viral glycoproteins, such as influenza HA2 and HIV gp41, are anchored by a sin-
gle helical segment transmembrane domain (TMD) on the viral envelope mem-
brane. The function of the TMD’s is still unclear, but it is speculated to be
involved in the final steps of membrane fusion. The interactions between the
influenza HA fusion peptide (FP) and the TMD, as well as the HIV gp41 FP
and TMD have previously been shown. We found that the FP or TMD alone per-
turbs membrane structure. We hypothesized that the FP-TMD interaction will
further change the membrane structure which provides a driving force for the
fusion between the inner membranes. We used PC spin labels DPPTC (on the
head group), 5PC and 14PC (5-C and 14-C positions on the acyl chain) to detect
the perturbation by titrating the FP to TMD-reconstituted POPC/POPG/Chol
lipid bilayers by ESR. We found that the FP increases the lipid order in all posi-
tions. In addition to the increase of lipid order, multiple components are found for
5PC when the concentration of FP increases, indicating that distinct domains are
induced. The FP or TMD alone does not induce this change. Therefore, this
domain formation should be an effect of FP-TMD interaction. Although HA-
mediated membrane fusion is pH dependent, the domain formation is observed
at both pH5 and pH7. Themutations on TMDdo not affect the domain formation.
However, the deletion of G1 in the FP eliminates all perturbations. We conclude
that the influenza FP-TMD interaction induces distinct domains in the lipid bila-
yers, which is pH independent but relies on the glycine ridge in the N-terminal
helix of the FP. We are extending our research on ITC and ESR on spin-
labeled peptides to further characterize this interaction.
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Influenza Membrane Fusion as Viewed from the Structure and Dynamics
of the Full-Length Hemagglutinin Fusion Domain
Justin L. Lorieau1, John M. Louis2, Charles D. Schwieters3, Ad Bax2.
1Chemistry, University of Illinois, Chicago, Chicago, IL, USA, 2NIDDK,
National Institutes of Health, Bethesda, MD, USA, 3CIT, National Institutes
of Health, Bethesda, MD, USA.
The N-terminus of the influenza hemagglutinin HA2 subunit, known as the
fusion domain or fusion peptide, is critical to membrane fusion and influenza
cellular entry. It is one of the most conserved sequences in the influenza
genome such that modest mutation can arrest membrane fusion. Despite this
domain’s critical role to influenza membrane fusion and entry, there is no clear
consensus in the literature on this domain’s function. Research over the last 25
years focused on a fusiogenic 20-residue peptide of this domain, which adopts a
boomerang structure with an N-terminal a-helix and a partially disordered C-
terminus. We recently demonstrated that a peptide extending an additional
three completely conserved, hydrophobic residues was needed to accurately
model the fusion domain’s structure. The full-length fusion domain is more fu-
siogenic and adopts a distinct and unique helical-hairpin membrane protein
fold. The helical-hairpin is stabilized by four aliphatic CaHa-O hydrogen
bonds as well as a charge-dipole interaction at the N-terminus. With a new
NMR tool for measuring the dynamics of proteins in membranes, we uncovered
the surprisingly dynamic interaction of the fusion domain within membranes.
Finally, we reported a multiconformational NMR refinement strategy to reveal
the pH-triggered activated structures in the fusion domain, which could play a
role in forming a pore in the later stages of fusion.
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Pathogenic membrane-enveloped viruses cause devastating infectious diseases
and pose major biodefense threats. For these viruses, fusion of the viral mem-
brane with cellular membranes is essential for viral replication and infectivity.
For flaviviruses, alphaviruses, and many arenaviruses fusion occurs within en-
dosomes and is driven by pH-dependent conformational changes of a dedicated
708a Wednesday, February 19, 2014protein, called E in flaviviruses. The present work focuses on the dependence of
fusion on membrane composition for the flavivirus Dengue (DEN). Recently it
has been reported that full fusion only occurs with membranes containing
anionic lipids, i.e. late endosomes.1 The origin of this strong dependence on
lipid composition is currently unknown. Regarding cholesterol, different ef-
fects have been reported. One group reported that cholesterol is not absolutely
required but increases the efficiency of fusion of the flavivirus tick-borne en-
cephalitis (TBE) with liposomes.2 Another group reported that an excess of
cholesterol blocks fusion of DEN in mammalian cells.3 Others reported that
fusion of DEN in insect cells was independent of cholesterol.4 To provide
insight into the membrane dependence of fusion for DEN we used several
biophysical techniques (neutron reflectivity, quartz crystal microbalance, den-
sity gradient centrifugation and liposome coflotation analysis) to study the
depth of insertion of E into lipid membranes, the influence of E binding on
membrane curvature, and the anchoring energy of E in the membrane as a func-
tion of membrane composition. Important effects were discovered for both
negatively-charged lipids and cholesterol.
(1) Zaitseva et al PLoS Pathogens 2010, 6, e1001131.
(2) Stiasny et al Journal of Virology 2003, 77, 7856.
(3) Lee, et al Journal of Virology 2008, 82, 6470.
(4) Umashankar et al Journal of Virology 2008, 82, 9245.
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The Viral Restriction Factor IFITM3 Promotes Hemifusion but Blocks
Full Fusion of Influenza Virus
Tanay M. Desai1, Mariana Marin1, Christopher R. Chin2, George Savidis2,
Abraham L. Brass2, Gregory B. Melikyan1.
1Pediatrics, Emory University, Atlanta, GA, USA, 2Albert Sherman Center,
University of Massachusetts, Worcester, MA, USA.
Interferon-induced transmembrane proteins (IFITMs) are up-regulated as part of
a cell’s defense against viral challenges. These small proteins inhibit entry of
diverse viruses, such as influenza A (IAV), West Nile and dengue virus. The
mechanism by which IFITMs block viral entry is not understood. Recent reports
suggest that IFITMs inhibits viral hemifusion (merger of proximal leaflets of the
viral and cellular membranes), presumably by disrupting cholesterol trafficking
and causing aberrant cholesterol accumulation in late endosomes. Here we em-
ployed time-resolved single IAV imaging to identify fusion step(s) affected by
IFITM3 protein ectopically expressed in lung epithelial cells. These experiments
revealed that, contrary to previous reports, lipid mixing between IAV and endo-
somes was, in fact, promoted upon IFITM3 expression. In contrast, virus-cell
fusion assays monitoring the release of the viral content showed marked inhibi-
tion of fusion pore formation by IFITM3. This effect was not due to excessive
cholesterol accumulation in endosomes or to reduced endosome acidity in
IFITM3-expressing cells. Furthermore, conditions that induced the accumulation
of cholesterol in late endosomes/lysosomes did not restrict IAV fusion. To
conclude, IFITM3 blocks IAV fusion by disfavoring the formation of fusion
pores, and this phenomenon is independent of cholesterol levels. We propose
that IFITM3 can block viral fusion at a post-hemifusion stage either directly,
by inserting into and stabilizing the cytosolic leaflet of endosomal membranes,
or indirectly, by altering the lipid composition and thus disfavoring the formation
of fusion pores. This work was partially supported by the NIH R01 GM054787
(to GBM) and 1R01AI091786 (to ALB) grants.
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New Broad-Spectrum Viral Fusion Inhibitors Act by Deleterious Effect on
the Viral Membrane through the Production Singlet Oxygen Molecules
Axel Hollmann1, Marcelo T. Augusto1, Sonia Gonc¸alves1, Frederic Vigant2,
Miguel A.R.B. Castanho1, Benhur Lee2, Nuno C. Santos1.
1Instituto de Medcina Molecular, Lisbon, Portugal, 2Department of
Microbiology, Immunology and Molecular Genetics, UCLA, Los Angeles,
CA, USA.
Targeting membranes of enveloped viruses represents an exciting new para-
digm to explore regarding the development of broad-spectrum antivirals.
Recently, broad-spectrum small-molecule antiviral drugs were described,
which prevent enveloped virus entry at an intermediate step, after virus binding
but before virus-cell fusion [1, 2]. These compounds, an aryl methyldiene rho-
danine derivate, named LJ001, and oxazolidine-2,4-dithione derivates named
JL103 and JL 118, act deleteriously on the virus envelope but not at the cell
membrane level. The aim of the present work was to study the interactions
of active compounds (LJ001, JL103 and JL118) and LJ025 (an inactive analog
used as negative control) with biological membrane models, in order to clarify
the mechanism of action of these new enveloped virus entry inhibitors. Fluores-
cence spectroscopy was used to quantify the partition and determine the loca-
tion of the molecules on membranes. The ability of the compounds to produce
reactive oxygen molecules in the membrane was tested by using 9,10-dimethy-lanthracene, which reacts selectively with singlet oxygen. Changes on the lipid
packing and fluidity of membranes were assessed by fluorescence anisotropy
and generalized polarization measurements. Finally, the ability to inhibit mem-
brane fusion was evaluated using FRET. Our results indicate that singlet oxy-
gen production by LJ001, JL103 and JL118 is able to induce several changes on
membrane properties, specially related with a decrease on its fluidity, concom-
itant with an increase on the order on the polar head groups region, resulting in
an inhibition of the membrane fusion necessary for cell infection.
1. Wolf et al. (2010) PNAS 107, 3157-62.
2. Vigant et al. (2013) PLoS Pathog 9: e1003297.
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GP41 Ectodomain Dissociates and Forms a Stable Monomer on Phospho-
lipid Vesicles and Detergent Micelles: Implication for the HIV-1 Env-
Mediated Membrane Fusion
Julien Roche, John M. Louis, Ad Bax.
National Institutes of Health, Bethesda, MD, USA.
The first step of HIV infection involves the fusion of the viral and target cell
membranes, a process mediated by the viral envelope glycoproteins, gp120
and gp41. The binding of gp120 to the cell surface receptors CD4 triggers a
cascade of conformational changes that disrupt the gp41-gp120 interactions
and allows the insertion of the N-terminal fusion peptide of gp41 into the
host cell membrane. The gp41 trimer then rapidly folds into a 6-helix bundle
that pulls together the fusion peptide, inserted in the host cell membrane and
the transmembrane domain, located in the viral membrane. Very little structural
information is known about the pre-fusion state of gp41 notwithstanding its
critical importance for the design of fusion inhibitors. To investigate the dy-
namics and structural properties of such metastable states, we designed a set
of protein constructs mimicking the extracellular ectodomain of gp41. We
found that the secondary structure of gp41 ectodomain is pronouncedly
impacted by the presence of phospholipid vesicles or detergents containing
phosphatidyl choline head groups. Our NMR and multi-angle light scattering
data attribute these changes to the transition between a trimer in the absence
of detergent to a monomer in the presence of a membrane-mimicking environ-
ment. The structure of gp41 in a monomeric state was determined by state-of-
the-art NMR techniques, including measurements of NOE distance restraints
and residual dipolar couplings in weakly aligned solutions. 15N relaxation
data provided a detailed view at the backbone dynamics of both the trimeric
and monomeric conformations. This stable monomeric state may represent a
crucial structural intermediate facilitating both the gp41 conformational change
during fusion and the local apposition of the viral and cellular membranes.
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Single-Molecule Manipulation of Gp41 Folding Involved in HIV Infection
and Drug Resistance
Junyi Jiao, Yongli Zhang.
Yale University, New Haven, CT, USA.
The HIV-1 envelope (Env) glycoprotein, a homotrimeric complex of gp41 and
gp120, mediates attachment and fusion of the HIV-1 virion to its host CD4
cells, the very first and rate-limiting step of HIV infection. The complex holds
gp41 in a largely unfolded high energy state like a loaded spring. The virion
attachment triggers profound conformational rearrangements of Env protein
that couple gp41 folding to membrane fusion by an unknown mechanism. In
this process, gp41 folds from a pre-hairpin structure into a trimer-of-hairpins
structure containing a six-helix bundle. Each hairpin contains an N- and a C-ter-
minal helix linked by a loop. Here, we characterized the energetics and kinetics
of gp41 folding at a single molecule level using high-resolution optical twee-
zers. Our data showed that single gp41 complexes fold in a two-state manner
independent of the solution pH value, releasing extraordinary high energy
competent for membrane fusion. As the sole antigen on the virion surface,
HIV Env complexes are primary targets for anti-HIV drugs and vaccine devel-
opment. Our work will provide important insights into the mechanism of HIV-1
fusion and drug resistance and help improve anti-HIV medicines.
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The Gp41 Sequence Connecting Mper and Tm Domains Constitutes a
Distinct HIV-1 ‘‘Fusion Peptide’’ Targeted by Neutralizing Antibodies
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The HIV-1 virus makes use of a membrane fusion strategy to enter into the
host cell. As such, this process constitutes a clinical target for inhibitor and
